Docteur SOPHIE POUPLIN
✨ Profil synthétique
IA · 04/05/2026Le Docteur Sophie Pouplin est une rhumatologue hospitalière à Rouen, titulaire d'un DIU en douleur. Elle est auteur de 147 publications et son h-index est de 22. Ses recherches portent principalement sur les maladies rhumatismales, notamment la polyarthrite rhumatoïde et les spondylarthropathies.
Expertises présumées
- Polyarthrite rhumatoïde
- Spondylarthropathies
- Douleur musculosquelettique
- Lupus érythémateux systémique
- Thérapies anti-TNF
- Biothérapies non anti-TNF
- Pharmacovigilance en rhumatologie
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎯 Capacités
- Evaluation et Traitement de la douleur (CAPA)
🎓 Diplômes
- DE Docteur en médecine
📝 Autres formations
- Evaluation et traitement de la douleur
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
🏆 DU / DIU rhumato reconnus
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
22
h articles cités ≥ h fois chacun. Un h de 22 = 22 publications avec 22+ citations.
Citations
2 020
Publications
147
i10-index
31
Thématiques principales
- Rheumatoid Arthritis Research and Therapies ×78
- Spondyloarthritis Studies and Treatments ×39
- Musculoskeletal pain and rehabilitation ×18
- Systemic Lupus Erythematosus Research ×17
- Autoimmune and Inflammatory Disorders Research ×17
Affiliations FR : Centre Hospitalier Universitaire de Rouen · Université de Rouen Normandie
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
A systematic standardized global assessment of chronic inflammatory rheumatism: Benefits and limitations
2025ArticleRevue du Rhumatisme
Determinants associated with the prescription of a first biologic therapy in patients with axial spondyloarthritis and concomitant fibromyalgia in daily practice
2024ArticleJoint Bone Spine
Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative
2024ArticleJoint Bone Spine
An Overview of Opioid Prescription Patterns among Non-Opioid Users Following Emergency Department Admission
2024ArticleHealthcare
Impact of Clinical Pharmacist Consultations on Postoperative Pain in Ambulatory Surgery
2023ArticleInternational Journal of Environmental Research and Public Health
eDOL mHealth App and Web Platform for Self-monitoring and Medical Follow-up of Patients With Chronic Pain: Observational Feasibility Study
2022ArticleJMIR Formative Research
Association Between the Number of Comorbidities and the Risk of a Serious Infection in Rheumatoid Arthritis Treated by a First Biologic Agent
2022ArticleJCR: Journal of Clinical Rheumatology
Efficacy of a Nurse-Led Patient Education Intervention in Promoting Safety Skills of Patients with Inflammatory Arthritis Treated with Biologics: A Multicentre Randomised Clinical Trial
2022ArticleRMD Open : Rheumatic & Musculoskeletal Diseases
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Localisation
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieu de consultation
HOPITAL CHARLES NICOLLE CHU ROUEN
1 Rue DE GERMONT, 76000 Rouen
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Articles de presse (3)
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
- Opioïdes et douleurs chroniques non cancéreuses : initiation, poursuite et arrêt d’un traitement prolongé - vidal.fr
📰 vidal.fr · 19/03/2026
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxNdHR0ZVhGbUZYNXAwRHhVX2t1RlBYQXRQQUlRV2MyOTBWa25ISE5BRnVuaTBXTkpKNHhGS1hRU09faFZ6VmpKVDg2OFJ6ejJwOGt3X0hUSFJ2OTN3TDg0N196Y2xocEFGSXhkSlZ1VEpvT2FHajlxMlU0UTR4M1dCTVpHMDA3NEYtNXNteXBmSTMxS1R0TGRZbUNYd0Naa0hmR2xUcnNnT3JQSncxa211alB6bkpxM2NSbW
- Opioïdes : indications et troubles de l’usage dans les douleurs chroniques non cancéreuses - vidal.fr
📰 vidal.fr · 17/03/2026
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxPb0xEb0d4bWo5T0RuSkp6YzI3bkV4N05JS0I3ZEFtZnZ6RUZveDdXd21SbWlsNTZwNjJVQ2JVcWQ3NHgzTFpSanJTVk1Ed0dqQ2V5T1l3U3lhRGV5T3pEbkREdnVuWFhkYnFQWkpmM1BYWWZ5RndCcUVhSEU2TFdPMzIzcFdJVE5mekhLQmtuUU5ySlc5Y2ljWENDc1YzMUFONkw3OC0tVUp2a3ZmQjlCVUZUd082M29vQV
- Des casques de réalité virtuelle pour traiter la douleur au CHU de Rouen - Le Parisien
📰 Le Parisien · 20/02/2020
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxOQnU4M19wRkRSUUZfdEY4b0hHZEt2a2ZpS2tRNm16MTNDR0lOQzZtUU1PM3JkcUgwWGxhMTFpTzJkZUkzRThpODNWbU1ocHE0akdhbzhpdUJ3emxuSm9MRFpLY0NSNlJkNWlNN1hEcThBVFlvWFVTcnRDTVpBSlVEaFRtS05jWHVSZWY4Vm5qM3o5N2l3WlV2Y2IzLUZLUlNWS3ZxeG03V3p6RHBicTlRNnhzMDY1dG12LW
Top publications · les plus citées
- 1Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry
Arthritis and rheumatism · 2009
📚 455 citations🎯 RCR 13.85Top 1% NIH🔓 Open AccessLire l'abstract Crossref ↓
AbstractObjectiveTuberculosis (TB) is associated with anti–tumor necrosis factor (anti‐TNF) monoclonal antibody (mAb) therapy, but whether this association is drug‐specific remains a concern. Our objective was to describe cases of TB associated with anti‐TNF mAb therapy, identify risk factors, and estimate the incidence.MethodsWe conducted an incidence study and a case–control analysis to investigate the risk of newly diagnosed TB associated with the use of anti‐TNF agents. As part of the French Research Axed on Tolerance of Biotherapies (RATIO) registry, for 3 years we collected cases of TB among French patients receiving anti‐TNF mAb therapy for any indication; for each case, 2 patients treated with anti‐TNF agents served as control subjects.ResultsWe collected 69 cases of TB in patients treated for rheumatoid arthritis (n = 40), spondylarthritides (n = 18), inflammatory colitis (n = 9), psoriasis (n = 1) and Behçet's disease (n = 1) with infliximab (n = 36), adalimumab (n = 28), and etanercept (n = 5). None of the patients had received correct chemoprophylactic treatment. The sex‐ and age‐adjusted incidence rate of TB was 116.7 per 100,000 patient‐years. The standardized incidence ratio (SIR) was 12.2 (95% confidence interval [95% CI] 9.7–15.5) and was higher for therapy with infliximab and adalimumab than for therapy with etanercept (SIR 18.6 [95% CI 13.4–25.8] and SIR 29.3 [95% CI 20.3–42.4] versus SIR 1.8 [95% CI 0.7–4.3], respectively). In the case–control analysis, exposure to infliximab or adalimumab versus etanercept was an independent risk factor for TB (odds ratio [OR] 13.3 [95% CI 2.6–69.0] and OR 17.1 [95% CI 3.6–80.6], respectively). Other risk factors were age, the first year of anti‐TNF mAb treatment, and being born in an endemic area.ConclusionThe risk of TB is higher for patients receiving anti‐TNF mAb therapy than for those receiving soluble TNF receptor therapy. The increased risk with early anti‐TNF treatment and the absence of correct chemoprophylactic treatment favor the reactivation of latent TB.
- 3Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial
Annals of the rheumatic diseases · 2021
Publications scientifiques (50) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal32
▼
Transversal32
▼- An inflammatory mass of periodontoid space resulting from calcium crystal deposition
Joint bone spine · 2026 · Journal Article
Pouplin S, Baril M, Hebant B
- An Overview of Opioid Prescription Patterns among Non-Opioid Users Following Emergency Department Admission
Healthcare (Basel, Switzerland) · 2024 · Journal Article
Zeino M, Léguillon R, Brevet P, Gerard B, et al.
- Determinants associated with the prescription of a first biologic therapy in patients with axial spondyloarthritis and concomitant fibromyalgia in daily practice
Joint bone spine · 2024 · Journal Article
Renouprez T, Gillibert A, Gerard B, Pouplin S, et al.
- Impact of Clinical Pharmacist Consultations on Postoperative Pain in Ambulatory Surgery
International journal of environmental research and public health · 2023 · Journal Article
Barat E, Chenailler C, Gillibert A, Pouplin S, et al.
📚 3 cit.🎯 RCR 1.02 - Association Between the Number of Comorbidities and the Risk of a Serious Infection in Rheumatoid Arthritis Treated by a First Biologic Agent
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2022 · Journal Article
Banse C, Houivet E, Loison A, Varin R, et al.
- Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis
Rheumatology international · 2022 · Journal Article
Rodère M, Pereira B, Soubrier M, Fayet F, et al.
📚 4 cit. - eDOL mHealth App and Web Platform for Self-monitoring and Medical Follow-up of Patients With Chronic Pain: Observational Feasibility Study
JMIR formative research · 2022 · Journal Article
Kerckhove N, Delage N, Cambier S, Cantagrel N, et al.
📚 12 cit.🎯 RCR 1.80🔬→🩺 Translationnel - Clinical impact of a personalized pharmaceutical plan on opioid management in non-cancer pain: a pilot study
Clinical rheumatology · 2021 · Journal Article
Lattard C, Chenailler C, Soubieux A, Gillibert A, et al.
📚 3 cit.🩺 Clinique - Opioid epidemic: Does rheumatological practice favors risk for patients? National survey on rheumatologists' opioid prescriptions and compliance to guidelines for strong opioid prescription
Joint bone spine · 2021 · Journal Article
Trouvin AP, Chenaf C, Riquelme M, Curis E, et al.
📚 2 cit.🔬→🩺 Translationnel - Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approaches
Joint bone spine · 2020 · Journal Article
Baillet A, Romand X, Pflimlin A, Dalecky M, et al.
📚 7 cit.🔬→🩺 Translationnel - Agreement with the French 2019 recommendations on treatment adherence in rheumatic diseases among 357 health professionals
Joint bone spine · 2020 · Letter
Gossec L, Molto A, Beauvais C, Senbel E, et al.
- Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
Clinical rheumatology · 2020 · Journal Article
Monchablon C, Gondé H, Pouplin S, Varin R, et al.
📚 8 cit.🔬→🩺 Translationnel - Self-reported competencies and educational needs of rheumatology nurses: Results of a national survey
Joint bone spine · 2020 · Letter
Beauvais C, Gossec L, Mulliez A, Fayet F, et al.
📚 1 cit. - Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study
BMJ open · 2019 · Journal Article
Vittecoq O, Desouches S, Kozyreff M, Nicolau J, et al.
📚 10 cit.🩺 Clinique - Essential knowledge for patients with rheumatoid arthritis or spondyloarthritis: Results of a multicentric survey in France among health professionals and patients
Joint bone spine · 2019 · Comparative Study
Beauvais C, Rodère M, Pereira B, Legoupil N, et al.
📚 12 cit. - Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients
Rheumatology (Oxford, England) · 2019 · Letter
Gossec L, Fayet F, Soubrier M, Foissac F, et al.
📚 5 cit.🩺 Clinique - Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients
RMD open · 2019 · Comparative Study
Gossec L, Soubrier M, Foissac F, Molto A, et al.
📚 15 cit.🩺 Clinique - Development of a comorbidity self-questionnaire for patients with inflammatory joint disease
Joint bone spine · 2018 · Letter
Pouplin S, Gossec L, Fayet F, Savel C, et al.
📚 3 cit.🔬→🩺 Translationnel - Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France
Joint bone spine · 2016 · Journal Article
Gossec L, Baillet A, Dadoun S, Daien C, et al.
📚 20 cit.🔬→🩺 Translationnel - Early phase clinical and biological markers associated with subclinical atherosclerosis measured at 7 years of evolution in an early inflammatory arthritis cohort
Clinical and experimental rheumatology · 2016 · Journal Article
Vandhuick T, Allanore Y, Borderie D, Louvel JP, et al.
📚 10 cit.🔬→🩺 Translationnel - Validation of the 2010-ACR/EULAR -classification criteria using newly EULAR-defined erosion for rheumatoid arthritis on the very early arthritis community-based (VErA) cohort
Joint bone spine · 2015 · Journal Article
Le Loët X, Nicolau J, Boumier P, Daragon A, et al.
📚 14 cit.🔬→🩺 Translationnel - Estimated medication costs of primary TNFα antagonist failure in patients with rheumatoid arthritis
Joint bone spine · 2012 · Letter
Rose E, Lequerré T, Pouplin S, Daragon A, et al.
📚 1 cit. - Pain due to osteoarthritis may impair the early outcome of deep brain stimulation in Parkinson's disease
Clinical neurology and neurosurgery · 2011 · Journal Article
Genty S, Derrey S, Pouplin S, Lefaucheur R, et al.
📚 5 cit. - Combining anti-cyclic citrullinated peptide with the American College of Rheumatology 1987 criteria failed to improve early rheumatoid arthritis diagnosis in the community-based very early arthritis cohort
Rheumatology (Oxford, England) · 2011 · Clinical Trial
Le Loët X, Strotz V, Lequerré T, Boumier P, et al.
📚 9 cit.🩺 Clinique - Gene profiling predicts rheumatoid arthritis responsiveness to IL-1Ra (anakinra)
Rheumatology (Oxford, England) · 2011 · Clinical Trial
Bansard C, Lequerré T, Derambure C, Vittecoq O, et al.
📚 25 cit.🩺 Clinique - Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort
Arthritis care & research · 2010 · Comparative Study
Le Loët X, Brazier M, Mejjad O, Boumier P, et al.
📚 17 cit.🔬→🩺 Translationnel - Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra
Rheumatology (Oxford, England) · 2007 · Case Reports
Lequerré T, Vittecoq O, Pouplin S, Klemmer N, et al.
📚 24 cit.🔬→🩺 Translationnel - Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction
Clinical immunology (Orlando, Fla.) · 2007 · Journal Article
Clavel G, Bessis N, Lemeiter D, Fardellone P, et al.
📚 66 cit.🎯 RCR 1.85🔬→🩺 Translationnel - Concomitant eosinophilia, fasciitis, and mycosis fungoides-like reaction with antinuclear autoantibodies in chronic myeloid leukaemia: role of a T-cell clone induced by imatinib
The Lancet. Oncology · 2005 · Case Reports
Jardin F, Courville P, Lenain P, Lenormand B, et al.
📚 5 cit. - Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis
Arthritis research & therapy · 2005 · Journal Article
Goëb V, Dieudé P, Vittecoq O, Mejjad O, et al.
📚 16 cit. - Foot orthotics decrease pain but do not improve gait in rheumatoid arthritis patients
Joint bone spine · 2004 · Clinical Trial
Mejjad O, Vittecoq O, Pouplin S, Grassin-Delyle L, et al.
📚 37 cit.🎯 RCR 1.79🩺 Clinique - Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis
Clinical and experimental immunology · 2004 · Journal Article
Jouen F, Vittecoq O, Leguillou F, Tabti-Titon I, et al.
📚 17 cit.🔬→🩺 Translationnel
Essai clinique6
▼
Essai clinique6
▼- Comparison of group versus individual patient education for promoting safety skills of patients with autoimmune rheumatic diseases treated with biologics: a multicentre randomised controlled trial
Clinical rheumatology · 2025 · Journal Article
Fayet F, Beauvais C, Pereira B, Béranger M, et al.
📚 3 cit.🩺 Clinique - Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics: a multicentre randomised clinical trial
RMD open · 2022 · Journal Article
Beauvais C, Fayet F, Rousseau A, Sordet C, et al.
📚 19 cit.🎯 RCR 2.40🩺 Clinique - Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial
Annals of the rheumatic diseases · 2021 · Journal Article
Molto A, López-Medina C, Van den Bosch FE, Boonen A, et al.
📚 93 cit.🎯 RCR 7.65🩺 Clinique - Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA)
Rheumatology (Oxford, England) · 2021 · Journal Article
Molto A, Gossec L, Poiraudeau S, Claudepierre P, et al.
📚 20 cit.🎯 RCR 1.84🩺 Clinique - Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial
Seminars in arthritis and rheumatism · 2020 · Journal Article
Molto A, Gossec L, Poiraudeau S, Claudepierre P, et al.
📚 6 cit.🩺 Clinique - Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA)
Annals of the rheumatic diseases · 2015 · Journal Article
Dougados M, Soubrier M, Perrodeau E, Gossec L, et al.
📚 106 cit.🎯 RCR 5.01🩺 Clinique
Anti-TNF4
▼
Anti-TNF4
▼- Impact of ACR 2010 fibromyalgia criteria fulfillment on disease activity evaluation in patients with axial spondyloarthritis treated with infliximab
Joint bone spine · 2019 · Letter
Dantu A, Michaud J, Bréhier Q, Banse C, et al.
📚 3 cit.🩺 Clinique - Switching from an anti-TNF monoclonal antibody to soluble TNF-receptor yields better results than vice versa: An observational retrospective study of 72 rheumatoid arthritis switchers
Joint bone spine · 2015 · Journal Article
Lequerré T, Farran É, Ménard JF, Kozyreff-Meurice M, et al.
📚 17 cit.🩺 Clinique - A 3 mg/kg starting dose of infliximab in active spondyloarthritis resistant to conventional treatments is efficient, safe and lowers costs
Joint bone spine · 2011 · Journal Article
Tenga G, Goëb V, Lequerré T, Bacquet-Deschryver H, et al.
📚 15 cit.🔬→🩺 Translationnel - Management of infusion reactions to infliximab in patients with rheumatoid arthritis or spondyloarthritis: experience from an immunotherapy unit of rheumatology
The Journal of rheumatology · 2006 · Journal Article
Lequerré T, Vittecoq O, Klemmer N, Goëb V, et al.
📚 40 cit.🎯 RCR 1.25🔬→🩺 Translationnel
Épidémiologie & registres2
▼
Épidémiologie & registres2
▼- Prevalence of Renal Impairment in Patients With Rheumatoid Arthritis: Results From a Cross-Sectional Multicenter Study
Arthritis care & research · 2016 · Journal Article
Couderc M, Tatar Z, Pereira B, Tiple A, et al.
📚 27 cit.🎯 RCR 1.14🔬→🩺 Translationnel - Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry
Arthritis and rheumatism · 2009 · Journal Article
Tubach F, Salmon D, Ravaud P, Allanore Y, et al.
📚 455 cit.🎯 RCR 13.85🔬→🩺 Translationnel
Pharmacovigilance2
▼
Pharmacovigilance2
▼- Comparison of group versus individual patient education for promoting safety skills of patients with autoimmune rheumatic diseases treated with biologics: a multicentre randomised controlled trial
Clinical rheumatology · 2025 · Journal Article
Fayet F, Beauvais C, Pereira B, Béranger M, et al.
📚 3 cit.🩺 Clinique - Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics: a multicentre randomised clinical trial
RMD open · 2022 · Journal Article
Beauvais C, Fayet F, Rousseau A, Sordet C, et al.
📚 19 cit.🎯 RCR 2.40🩺 Clinique
Recommandations2
▼
Recommandations2
▼- Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative
Joint bone spine · 2024 · Consensus Statement
Ruyssen-Witrand A, Caillet-Portillo D, Najm A, Fogel O, et al.
📚 1 cit. - Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus
Joint bone spine · 2019 · Journal Article
Gossec L, Molto A, Romand X, Puyraimond-Zemmour D, et al.
📚 29 cit.🎯 RCR 2.03🔬→🩺 Translationnel
Biothérapies non-anti-TNF1
▼
Biothérapies non-anti-TNF1
▼- Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life study
Clinical and experimental rheumatology · 2023 · Multicenter Study
Vittecoq O, Kozyreff-Meurice M, Houivet E, Leon N, et al.
Économie santé1
▼
Économie santé1
▼- The burden of pain in rheumatoid arthritis: Impact of disease activity and psychological factors
European journal of pain (London, England) · 2020 · Journal Article
Vergne-Salle P, Pouplin S, Trouvin AP, Bera-Louville A, et al.
📚 65 cit.🎯 RCR 4.55🔬→🩺 Translationnel
Lombalgie1
▼
Lombalgie1
▼- Development and validation of a questionnaire categorizing behavioral strategies in patients with chronic low back pain
Joint bone spine · 2017 · Journal Article
Bailly F, Foltz V, Rozenberg S, Norberg M, et al.
📚 2 cit.🩺 Clinique
Revue générale1
▼
Revue générale1
▼- Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review
RMD open · 2018 · Journal Article
Lavielle M, Puyraimond-Zemmour D, Romand X, Gossec L, et al.
📚 39 cit.🎯 RCR 2.62🔬→🩺 Translationnel
Stratégie thérapeutique1
▼
Stratégie thérapeutique1
▼- Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial
Annals of the rheumatic diseases · 2021 · Journal Article
Molto A, López-Medina C, Van den Bosch FE, Boonen A, et al.
📚 93 cit.🎯 RCR 7.65🩺 Clinique